A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC
PHASE2
The goal of this clinical trial is to learn if tislelizumab in combination ...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
PHASE3
Neoadjuvant chemotherapy combined with immunotherapy has achieved promising...
An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian Cancer
PHASE2
The R0 resection rate in neoadjuvant chemotherapy for advanced ovarian canc...